← Eichor
Condition: Als Frontotemporal Dementia Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Als Frontotemporal Dementia

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

The Pre-symptomatic Familial Amyotrophic Lateral Sclerosis (Pre-fALS) Study
Phase N/A · 1 location(s) · University of Miami · NCT00317616Investigating Complex Neurodegenerative Disorders Related to Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
Phase N/A · 1 location(s) · National Institute of Neurological Disorders and Stroke (NIN · NCT03225144Proteinopathies Expression in Skin of Neurodegenerative Disorders
Phase N/A · 1 location(s) · Universidad Autonoma de San Luis Potosí · NCT06528964Clinical Procedures to Support Research in ALS
Phase N/A · 11 location(s) · University of Miami · NCT03489278ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)
Phase N/A · 27 location(s) · Mayo Clinic · NCT04363684Amyotrophic Lateral Sclerosis (ALS) Families Project
Phase N/A · 1 location(s) · Columbia University · NCT03865420ALS Research Collaborative
Phase N/A · 1 location(s) · ALS Therapy Development Institute · NCT06885918Retinal Imaging in Neurodegenerative Disease
Phase N/A · 1 location(s) · Duke University · NCT03233646The Swedish BioFINDER 2 Study
NA · 2 location(s) · Skane University Hospital · NCT03174938Effects of Probiotics in Amyotrophic Lateral Sclerosis-Frontotemporal Dementia Spectrum Disorder (ALS-FTDSD) Patients
NA · 3 location(s) · Centre hospitalier de l'Université de Montréal (CHUM) · NCT06051123Advances in Telephone-based Cognitive Screening Procedures
Phase N/A · 1 location(s) · Istituto Auxologico Italiano · NCT06337578Ultra-High Resolution PET in Aging, Neurodegeneration and Psychotic Disorders
NA · 1 location(s) · Universitaire Ziekenhuizen KU Leuven · NCT07509125[18F]ACI-19626 PET in TDP-43 Proteinopathies
EARLY_Phase 1 · 1 location(s) · AC Immune SA · NCT06891716Disease Biosignatures in ALS/FTD Spectrum: New Impactful Biological Perspectives Beyond Clinical Approaches
Phase N/A · 4 location(s) · Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta · NCT06856850UPenn Observational Research Repository on Neurodegenerative Disease
Phase N/A · 1 location(s) · University of Pennsylvania · NCT04715399NYSCF Scientific Discovery Biobank
Phase N/A · 1 location(s) · New York Stem Cell Foundation Research Institute · NCT06203106Diagnosing Frontotemporal Lobar Degeneration
Phase N/A · 1 location(s) · University Health Network, Toronto · NCT02964637Neurodegenerative Diseases Progression Markers (MARKERS-NDD)
Phase N/A · 1 location(s) · Casa di Cura San Raffaele Cassino · NCT06596746Using the EHR to Advance Genomic Medicine Across a Diverse Health System
NA · 1 location(s) · University of Pennsylvania · NCT06377033Neurologic Stem Cell Treatment Study
NA · 3 location(s) · MD Stem Cells · NCT02795052Discovery and Validation of Protein Structural Complexes in Circulating Biofluids As Novel Biomarkers for Early Diagnosi
Phase N/A · 1 location(s) · Neuromed IRCCS · NCT06803784Genetics and Environment iNtersection In the ALS-FTD Spectrum: an Italian Twins Cohort studY With a Multi-Omics Approach
Phase N/A · 3 location(s) · Azienda Ospedaliero-Universitaria di Modena · NCT06595212
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.